Clinical utility of the combination of cognitive-behavioral techniques with nicotine patches as a smoking-cessation treatment: Five-year results of the “Ex-Moker” program

References 

1. American Psychiatric Association. Practice guideline for the treatment of patients with nicotine dependence. American Journal of Psychiatry. 1996;153:1–31
2. Becoña E. Evaluación de la conducta de fumar ((Smoking-behavior assessment)), In:  Graña JL editors. Conductas adictivas. Teoría, evaluación y tratamientoMadrid: Debate; 1994;p. 403–454
3. Becoña E, Vázquez FL. Estado actual de las alternativas terapéuticas para dejar de fumar ((The state of the art of smoking-cessation therapeutic approaches)), Adicciones. 1998;1:69–83
4. Becoña E, Vázquez FL. Self-reported smoking and measurement of expired air carbon monoxide in a clinical treatment. Psychological Reports. 1998;83:316–318
   • MEDLINE
   • CrossRef
5. Becoña E, Vázquez FL. The course of relapse across 36 months for smokers from a smoking-cessation program. Psychological Reports. 1998;82:142–146
6. Ciba. Nicotinell TTS. El sistema transdérmico de nicotina de Ciba ((Nicotinell TTS. Ciba nicotine transdermal system)), Barcelona: Ciba. División Farmacéutica; 1993;
7. Daughton DM, Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, et al. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Preventive Medicine. 1999;28:113–118
8. Fagerström KO. Measuring degree of physical dependence on tobacco smoking with reference to individualization of treatment. Addictive Behaviors. 1978;3:235–241
   • MEDLINE
   • CrossRef
9. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Smoking cessation. Clinical Practice Guideline No 18 (AHCPR Publication 96–0692). Rockville, M.D.: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996;
10. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Treating tobacco use and dependence. A clinical practice guideline. Rockville, MD: US Department of Health and Human Services; 2000;AHRQ publication No. 00 0032
11. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. Journal of the American Medical Association. 1994;271:1940–1947
12. Garrido Rodríguez P, Castillo Herráiz I, Colomer Revuelta C. ¿Son efectivos los tratamientos para dejar de fumar? Meta-análisis de la literatura sobre deshabituación tabáquica ((Are smoking cessation treatment effective? Meta-analysis of the literature on tobacco dishabituation)), Adicciones. 1995;7:211–225
13. Hajek P. Breath-holding and success in stopping smoking: What does breath-holding measure?. The International Journal of the Addictions. 1989;24:633–639
    • MEDLINE
14. Jolicoeur DG, Ahluwalia JS, Richter KP, Mosier M, Harris KJ, Gibson C, et al. The use of nicotine patches with minimal intervention. Preventive Medicine. 2000;30:504–512
15. Lando AH. Treatment outcome evaluation methodology in smoking cessation: Strengths and key issues. Advances in Behaviour Research and Therapy. 1989;11:201–214
16. Lichtenstein E, Glasgow RE. Smoking cessation: What we have learned over the past decade?. Journal of Consulting and Clinical Psychology. 1992;60:518–527
    • MEDLINE
    • CrossRef
17. Nebot M, Cabezas C, Oller M, Moreno F, Rodrigo J, Sardà T, et al. Consejo médico, consejo de enfermería y chicle de nicotina para dejar de fumar en atención primaria ((Medical counselling, nursing counselling, and nicotine gums for smoking cessation in primary care)), Medicina Clínica. 1990;95:57–61
    • MEDLINE
18. Ockene JK, Emmons KM, Mermelstein RJ, Perkins KA, Bonollo DS, Voorhees CC, et al. Relapse and maintenance issues for smoking cessation. Health Psychology. 2000;19(Suppl 1):17–31
19. Pardell H, Salto E, Ciruela J, Tresserras R, Gascon P, Salleras L. Programa de cesación tabáquica con parche de nicotina en médicos y farmacéuticos de Cataluña: resultados a 3 y 12 meses ((Smoking cessation program with nicotine patch in physicians and pharmacists from Catalonia: 3- and 12-month results)), Anales de Medicina Interna. 1996;13:16–20
20. Richmond RL, Kehoe L, Cesar A, Neto A. Three-year continuous abstinence in a smoking cessation study using the nicotine transdermal patch. Heart. 1997;78:617–618
    • MEDLINE
21. Sánchez Meca J, Martín Martínez F, Olivares Rodríguez J, Rosa Alcázar AI. Variables influyentes en el tratamiento de la adicción al tabaco. Un estudio de las tasas de abstinencia en España ((Influential variables in tobacco addiction treatment. A study on the abstinence rates in Spain)), Psicología Conductual. 1999;7:301–321
22. Sánchez Meca J, Olivares Rodríguez J, Rosa Alcázar A. The problem of tobacco addiction: Meta-analysis of behavioural treatments in Spain. Psychology in Spain. 1999;3:36–45
23. Tonnesen P, Norregaard J, Sawe U. Two-year outcome in a smoking cessation trial with a nicotine patch. Journal of Smoking Related Diseases. 1992;3:241–245
24. U.S. Department of Health and Human Services. The health benefits of smoking cessation: A Report of the Surgeon General (USDHHS Publication CDC 90–8416). Washington, DC: U.S. Department of Health and Human Services; 1990;
25. Vázquez FL, Becoña E. Los programas conductuales para dejar de fumar. Eficacia a los 2–6 años de seguimiento ((Behavioral programs for smoking cessation. Efficacy at 2–6-year follow-up)), Adicciones. 1996;8:369–392